Business, energy, technology, markets and global industry news from Business News Today

National Heart Lung and Blood Institute

PharmaDeviceNews National Heart Lung and Blood Institute
Greenstone Biosciences is advancing patient-derived cardiac cell research to identify potential therapies targeting cardiac fibrosis and cardiomyopathy in Duchenne muscular dystrophy following an NIH R61 grant. Representative image.
Pharma & Biotech

Can Greenstone Biosciences turn patient-derived heart cells into a Duchenne cardiomyopathy drug?

Greenstone Biosciences secured an NIH R61 grant to discover cardiac fibrosis drugs for Duchenne muscular dystrophy using iPSC and AI models.

Read More
The BOND trial will test HeartGPS psychological support and breastfeeding care strategies for families affected by critical congenital heart disease. Representative image.
Pharma & Biotech

How the BOND trial will test prenatal mental health support for congenital heart disease

The BOND trial will test HeartGPS and breastfeeding support for families affected by critical congenital heart disease across 17 US centers.

Read More